NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Nanobiotix S.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$21.08−0.22 (-1.03%)
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Mar 31, 2026 | After market close | – | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Sep 30, 2025 | After market close | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Apr 2, 2025 | After market close | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Sep 18, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Apr 24, 2024 | After market close | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Sep 26, 2023 | After market close | – | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 14, 2023 | After market close | – | – | – |
| Q2 FY2022 Ended Jun 30, 2022 | Jul 13, 2022 | After market close | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Mar 30, 2022 | After market close | – | – | – |
Press releases
Announcements Nanobiotix filed with the SEC
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
EX-99.1 to Form 6-K
Nanobiotix Joins the Euronext Tech Leaders Index
EX-99.1 to Form 6-K
NANOBIOTIX Announces Closing of Global Offering
EX-99.1 to Form 6-K
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
EX-99.1 to Form 6-K
Nanobiotix Announces Launch of Global Follow-On Offering
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
NANOBIOTIX Statement Regarding Recent Media Speculation
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
NANOBIOTIX to Participate in Investor Conferences in March
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K
NANOBIOTIX to Participate in Jefferies London Healthcare Conference
EX-99.1 to Form 6-K
NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
EX-99.1 to Form 6-K
Voting Rights and Shares Capital of the Company
EX-99.1 to Form 6-K